Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea

November 13, 2026 updated by: Acurable Ltd.

Evaluación clínica de Una tecnología Ambulatoria Para diagnóstico Del sueño

This trial will aim to test a new wearable device for the diagnosis of Sleep Apnoea.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This clinical trial will test a new wearable device for the diagnosis of Sleep Apnoea against Multi-channel polygraphy and Polysomnography.

For Group 1 and Group 2, the patients who have been referred for a sleep apnoea diagnosis will undergo in-hospital overnight polysomnography while wearing the new wearable device. Performance (i.e. sensitivity and specificity) of the new device will be assessed against the gold standard system.

For Group 3 and 4, the patients who have been referred for a sleep apnoea diagnosis will undergo in-hospital overnight polysomnography while wearing the new wearable device and a CE-marked oximeter.

For Group 5, patients presenting clinical criteria of Restless Legs Syndrome who are being evaluated via sleep studies as part of a routine clinical care will undergo an overnight polysomnography while wearing the new wearable device system.

Study Type

Observational

Enrollment (Estimated)

296

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seville, Spain
        • Recruiting
        • Hospital Virgen Macarena Sevilla
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients who have been referred for suspicion of sleep apnoea

Description

Inclusion Criteria:

  • Patients who have been referred to a sleep clinic due to suspicion of sleep apnoea.
  • patients between the age of 18 yo and 80 yo

Exclusion Criteria:

  • who are not fluent in Spanish, or who have special communication needs.
  • Known allergy to the adhesive dressing.
  • patients with physical or mental impairments who would not be able to use the new technology on their own.
  • patients with very loose/saggy skin in the neck area which would unavoidably result on AcuPebble swinging if moving the neck.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 2: PSG and novel wearable device

75 patients will wear polysomnography at the same time as the Novel wearable device

patient will wear novel wearable device overnight along with normal standard of care

Group 3: PSG and novel wearable device (+ CE-marked pulse oximeter)

51 patients (plus up to 20% to account for possible dropouts) will wear polysomnography at the same time as the novel wearable device and a CE-marked pulse-oximeter.

patient will wear novel wearable device overnight along with normal standard of care

Group 4: Additional PSG and novel wearable device (+ CE-marked pulse oximeter)

Additional 75 consecutive patients will wear polysomnography at the same time as the novel wearable device and a CE-marked pulse-oximeter.

Group 1: Test Group

A first group of ~10-15 patients will be recruited, chosen from those who have been referred for a sleep apnea diagnosis. This group will not be used for performance validation, but rather to train all relevant staff on the different steps of the protocol and for the initial investigation of some of the secondary objectives related to usability.

Group 5: RLS

70 patients presenting clinical criteria compatible with Restless legs Syndrome and who are being evaluated for a sleep study as part of their routine clinical care will be included. The patients will wear standard polysomnography while simultaneously wearing the new wearable system (a total of 4 sensors: 1 sensor on the neck, 1 pulse oximeter on finger, and 1-2 sensors on the legs).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivities and Specificity for diagnosis of sleep apnoea studies with novel wearable device
Time Frame: 6 months

The study aims to compare the diagnosis result of the novel wearable device against standard of care

6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Jesus Fernando Sanchez Gomez, MD, Hospital Universitario Virgen Macarena

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2019

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

July 18, 2019

First Submitted That Met QC Criteria

July 19, 2019

First Posted (Actual)

July 22, 2019

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 720/19/EC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.